SELECT: a 10% reduction in body weight with GLP-1 receptor agonists improves kidney outcomes in overweight and obese patients without diabetes
Nephrol Dial Transplant
.
2024 Sep 20:gfae207.
doi: 10.1093/ndt/gfae207.
Online ahead of print.
Authors
Marieta Theodorakopoulou
1
,
Marius Miglinas
2
,
Morten Buus Jørgensen
3
Affiliations
1
First Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece.
2
Nephrology Center, Santaros Klinikos, Medical Faculty, Vilnius University, Vilnius, Lithuania.
3
Department of Nephrology and Endocrinology, Rigshospitalet, Copenhagen, Denmark.
PMID:
39304535
DOI:
10.1093/ndt/gfae207
No abstract available